![]() |
|
|
Vol. 52, Issue 6, 1071-1080, 1997
2-Adrenergic
Receptor Subtypes in the Developing Mouse Embryo Suggests a Role for
the
2A Subtype in Apoptosis
Department of Pharmacology, Vanderbilt University School of
Medicine, Nashville, Tennessee 37232
2-Adrenergic receptors (
2-ARs) respond to
norepinephrine and epinephrine to mediate diverse physiological
effects. Using in situ hybridization, the expression
pattern of the mRNA encoding the three
2-AR subtypes
(
2A,
2B, and
2C) was
examined in the mouse embryo. The mRNA encoding the three subtypes was
first detected at stage 9.5 days postcoitus (d.p.c.) for the
2A-AR (coincident with norepinephrine availability),
11.5 d.p.c. for the
2B-AR, and 14.5 d.p.c. for
the
2C-AR subtype. The mRNA encoding the
2A-AR subtype shows both the earliest and the most
widespread expression pattern, including developing stomach and cecum,
many craniofacial regions and areas in the central nervous system. Strikingly, the
2A-AR mRNA is expressed in the
interdigital mesenchyme between stage 12.5 and 14.5 d.p.c. in
parallel with digit separation, raising the possibility that the
2A-AR might contribute to the apoptotic events
underlying this process. To test whether
2A-AR can
signal apoptotic events, the
2A-AR subtype was
introduced into two mouse mesenchymal cell lines,
C3H/10t1/2 and NIH-3T3; expression of the
2A-AR correlated with accelerated apoptosis, as detected
both by the TUNEL assay and the loss of cell viability. In contrast to
the wide distribution of mRNA encoding the
2A-AR subtype, the
2B-AR mRNA was detected only in the
developing liver and was most readily detectable between 11.5 and
14.5 d.p.c., when the liver is the principal site of
hematopoiesis. The
2C-AR mRNA is detected in the nasal
cavity and cerebellar primordium only at
14.5 d.p.c. These studies
represent the first characterization of the temporal and spatial
expressions of the
2A-AR,
2B-AR, and
2C-AR subtypes during embryogenesis and provide
important insights concerning the loci and possible roles of
2-AR-mediated regulation of physiological processes
during the developmental program.
This article has been cited by other articles:
![]() |
S. Cikos, P. Rehak, S. Czikkova, J. Vesela, and J. Koppel Expression of adrenergic receptors in mouse preimplantation embryos and ovulated oocytes Reproduction, June 1, 2007; 133(6): 1139 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Debrus, L. Rahbani, M. Marttila, B. Delorme, P. Paradis, and M. Nemer The Zinc Finger-Only Protein Zfp260 Is a Novel Cardiac Regulator and a Nuclear Effector of {alpha}1-Adrenergic Signaling Mol. Cell. Biol., October 1, 2005; 25(19): 8669 - 8682. [Abstract] [Full Text] [PDF] |
||||
![]() |
F B Kalapesi, M T Coroneo, and M A Hill Human ganglion cells express the alpha-2 adrenergic receptor: relevance to neuroprotection Br. J. Ophthalmol., June 1, 2005; 89(6): 758 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. KOLETSKY, R. A. VELLIQUETTE, and P. ERNSBERGER The Role of I1-Imidazoline Receptors and a2-Adrenergic Receptors in the Modulation of Glucose and Lipid Metabolism in the SHROB Model of Metabolic Syndrome X Ann. N.Y. Acad. Sci., December 1, 2003; 1009(1): 251 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Happe, D. B. Bylund, and L. C. Murrin Alpha-2 Adrenergic Receptor Functional Coupling to G Proteins in Rat Brain During Postnatal Development J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 1134 - 1142. [Abstract] [Full Text] |
||||
![]() |
F. A. Gesek {alpha}1- and {alpha}2-Adrenoceptor Control of Sodium Transport Reverses in Developing Hypertension Hypertension, January 1, 1999; 33(1): 524 - 529. [Abstract] [Full Text] [PDF] |
||||